Healthcare Analytics, Population Health Management, Healthcare Big Data

Genomics

EHR, Biobank Data Uncovers Genetics of Personalized Medicine

May 11, 2017 - Research led by Vanderbilt University Medical Center (VUMC) and University of Arizona’s College of Pharmacy effectively used EHR and biobank data to create a database that identifies specific genetic traits influencing personalized medicine. The researchers analyzed 30,000 genetic samples stored in BioVU, Vanderbilt’s genomics databank, linking the information with EHR data to...


More Articles

EHR, Biobank Data Uncovers Genetics of Personalized Medicine

by Thomas Beaton

Research led by Vanderbilt University Medical Center (VUMC) and University of Arizona’s College of Pharmacy effectively used EHR and biobank data to create a database that identifies specific genetic traits influencing personalized medicine....

FHIR Can Move Genomics from Prediction to Precision Medicine

by Jennifer Bresnick

In just a few short decades, the field of genomics has expanded dramatically, transitioning from a specialized discipline of academic biology into a mainstay of clinical care at academic medical centers, dedicated precision medicine hubs, and...

UVA Gene Mutation Research Method Speeds Precision Medicine

by Jennifer Bresnick

A team from the University of Virginia School of Medicine has developed a quicker way to examine the impact of gene mutation on patient health, potentially changing the way cancer labs conduct research into precision medicine and personalized...

EHRs, Value-Based Care Constrain Personalized Medicine Progress

by Jennifer Bresnick

Oncologists are eager to embrace the potential of personalized medicine and genetically-driven precision therapies, but face many of the technical, administrative, and reimbursement challenges that afflict their peers in other specialties, finds...

ONC Highlights Its Precision Medicine Initiative Collaborations

by Jennifer Bresnick

The Precision Medicine Initiative (PMI) is alive and well at the Office of the National Coordinator, where partnerships with other key government agencies are laying the big data groundwork for more personalized care.  Collaborations with...

NIH to Bring Precision Medicine Data Collection to Patient Homes

by Jennifer Bresnick

Thousands of volunteers for the All of Us precision medicine cohort won’t even have to leave the comfort of their living rooms when contributing data to the project thanks to a new NIH collaboration with mobile medical service EMSI. The...

Next-Generation Genomics, Precision Medicine to Top $100B

by Jennifer Bresnick

The markets for next-generation genomic testing tools and precision medicine software and services will be worth more than $100 billion by 2022, according to a new series of market reports, propelled by breakthroughs in cancer care, big data...

Precision Medicine, Population Health Share Strategies and Goals

by Jennifer Bresnick

Any organization that wants to have a hope of functioning smoothly divides its operations into distinct departments, each of which is in charge of a specific process.  Every member of the team contributes to the organization’s ultimate...

PGHD, Genomic Data Predicted to Power Clinical Decision Support

by Jennifer Bresnick

Patient-generated health data (PGHD) and individualized genomics are expected to become two of the most impactful data sources for clinical decision support, population health management, and care coordination over the next five years, according...

Point of Care Diagnostics Usher in Era of Personalized Medicine

by Jennifer Bresnick

Even before the advent of value-based care, healthcare providers have always faced pressure to do more, do it better, and do it faster while using fewer resources and producing high quality results.  As reimbursement changes tighten the...

Cancer Detection Company Gets $900M from Pharma, VC Investors

by Jennifer Bresnick

GRAIL, Inc., a precision medicine and life sciences company aiming to develop new very early detection techniques for cancer, has attracted more than $900 million in investment capital from some of the most well-known names in pharmaceutical...

Genomics, Clinical Decision Support Combo Cuts ED Visits by 42%

by Jennifer Bresnick

Providers who combined genetic testing with a clinical decision support tool to treat home health patients using multiple medications were able to reduce hospital readmissions by 52 percent and cut ED visits by 42 percent, according to a study...

NIH Renames Precision Medicine Cohort, Urges Patient Engagement

by Thomas Beaton

The newly unveiled All of Us Research Program, formally known as the Precision Medicine Initiative (PMI) Cohort, will help the NIH collect diverse patient data and foster patient engagement to support its million-member precision medicine biobank....

NIH Awards $21M to Precision Medicine Epilepsy Collaboration

by Jennifer Bresnick

An international academic research consortium will use precision medicine strategies and a new $21 million grant from the National Institutes of Health to further research into the development and treatment of epilepsy. The collaboration, spearheaded...

Precision Medicine Benefits Pediatric Cancer Care, Study Says

by Thomas Beaton

Investigators at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center found that precision medicine can be used to diagnose genetic abnormalities and properly treat patients with pediatric brain cancers. By testing tumor samples,...

Northwell Health Launches Precision Medicine, Cancer Biobank

by Thomas Beaton

Northwell Health and Indivumed are creating a new patient biobank to help expand opportunities for cancer research and the development of precision medicine therapies. In the three-year agreement announced in a press release this week, Northwell...

Cancer Research Orgs Release Big Data for Precision Medicine

by Jennifer Bresnick

The American Association for Cancer Research (AACR) is releasing more than 19,000 de-identified genomic records to further the international research community’s explorations into precision medicine.  The big data dump, which includes...

IBM Watson, Mount Sinai Launch New Precision Medicine Projects

by Jennifer Bresnick

Precision medicine partnerships are becoming all the rage as public and private healthcare organizations pool their expertise and resources to overcome the challenges of developing personalized treatments for cancer and other diseases. Some familiar...

Precision Medicine Partnerships Foster Promises of Breakthroughs

by Jennifer Bresnick

Precision medicine projects, partnerships, and collaborations are continuing to proliferate as providers, research organizations, and vendors look to capitalize on the growing enthusiasm for integrating genomics and personalized insights into...

API-Based Genomics Databank Facilitates Personalized Medicine

by Jennifer Bresnick

Genomic testing is becoming an increasingly common starting place for the development of personalized medicine treatments for patients with a variety of hard-to-treat diseases, especially cancer, but organizations often struggle with interpreting...

X

Join 25,000 of your peers

Register for free to get access to all our articles, webcasts, white papers and exclusive interviews.

Our privacy policy

no, thanks